US Patent

US7893097 — Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water

Formulation · Assigned to Dow Pharmaceutical Sciences Inc · Expires 2028-02-19 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects methods and compositions that increase the solubility of poorly soluble azole drug compounds, such as metronidazole, in water.

USPTO Abstract

The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid.

Drugs covered by this patent

Metro I.V. In Plastic Container (METRONIDAZOLE) · Baxter

Patent Metadata

Patent number: US7893097
Jurisdiction: US
Classification: Formulation
Expires: 2028-02-19
Drug substance claim: No
Drug product claim: Yes
Assignee: Dow Pharmaceutical Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.